(Q37289738)

19 August 2017

1 reference

title

Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good? (English)

1 reference

19 August 2017

0 references

0 references

Berger M

1

1 reference

19 August 2017

publication date

1 March 1991

1 reference

Clinical reviews in allergy

19 August 2017

published in

1 reference

19 August 2017

volume

9

1 reference

19 August 2017

issue

1-2

1 reference

19 August 2017

page(s)

119-142

1 reference

Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency

19 August 2017

cites work

1 reference

12 December 2020

Inactivation of human bronchial mucosal proteinase inhibitor by Pseudomonas aeruginosa elastase

1 reference

12 December 2020

Induction of phagocytic inhibitory activity in cats with chronic Pseudomonas aeruginosa pulmonary infection

1 reference

12 December 2020

Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration

1 reference

12 December 2020

Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease

1 reference

12 December 2020

Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis

1 reference

12 December 2020

Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin

1 reference

12 December 2020

Role of fibronectin in the prevention of adherence of Pseudomonas aeruginosa to buccal cells

1 reference

12 December 2020

Pseudomonas aeruginosa alkaline protease degrades human gamma interferon and inhibits its bioactivity

1 reference

12 December 2020

Studies on the mechanism of T cell inhibition by the Pseudomonas aeruginosa phenazine pigment pyocyanine

1 reference

12 December 2020

Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide

1 reference

12 December 2020

Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis

1 reference

12 December 2020

The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups

1 reference

12 December 2020

Hypogammaglobulinemia in patients with cystic fibrosis

1 reference

12 December 2020

Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface

1 reference

12 December 2020

Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage

1 reference

12 December 2020

Inactivation of human gamma interferon by Pseudomonas aeruginosa proteases: elastase augments the effects of alkaline protease despite the presence of alpha 2-macroglobulin

1 reference

12 December 2020

Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis

1 reference

12 December 2020

Inflammatory reaction and airway damage in cystic fibrosis

1 reference

12 December 2020

Fibronectin-cleaving activity in bronchial secretions of patients with cystic fibrosis

1 reference

12 December 2020

Effects of pyocyanine, a blue pigment from Pseudomonas aeruginosa, on separate steps of T cell activation: interleukin 2 (IL 2) production, IL 2 receptor formation, proliferation and induction of cytolytic activity.

1 reference

12 December 2020

Receptors for complement of leukocytes

1 reference

12 December 2020

Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis

1 reference

12 December 2020

Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells

1 reference

12 December 2020

Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema

1 reference

12 December 2020

Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis

1 reference

12 December 2020

Limited cleavage of human immunoglobulins by elastase of human neutrophil polymorphonuclear granulocytes. Possible modulator of immune complex disease

1 reference

12 December 2020

Release of inflammatory mediators from stimulated neutrophils.

1 reference

12 December 2020

Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis.

1 reference

12 December 2020

IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis.

1 reference

12 December 2020

Association with phagocytic inhibition of anti-Pseudomonas aeruginosa immunoglobulin G antibody subclass levels in serum from patients with cystic fibrosis

1 reference

12 December 2020

Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosis

1 reference

12 December 2020

Sputum sol-phase proteins and elastase activity in patients with cystic fibrosis.

1 reference

12 December 2020

Oxygen-dependent microbial killing by phagocytes (first of two parts).

1 reference

12 December 2020

Protease and elastase of Pseudomonas aeruginosa: inactivation of human plasma alpha 1-proteinase inhibitor

1 reference

12 December 2020

Potential mediator of inflammation. Phagocyte-derived oxidants suppress the elastase-inhibitory capacity of alpha 1-proteinase inhibitor in vitro

1 reference

12 December 2020

A novel neutrophil-activating factor produced by human mononuclear phagocytes

1 reference

12 December 2020

Elastase in tissue injury

1 reference

12 December 2020

Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats.

1 reference

12 December 2020

Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis

1 reference

12 December 2020

Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay

1 reference

12 December 2020

Interactions of Pseudomonas aeruginosa with immunoglobulins and complement in sputum

1 reference

12 December 2020

Adherence of streptococcus pyogenes, Escherichia coli, and Pseudomonas aeruginosa to fibronectin-coated and uncoated epithelial cells

1 reference

12 December 2020

Modulation of surface CD11/CD18 glycoproteins (Mo1, LFA-1, p150,95) by human mononuclear phagocytes

1 reference

12 December 2020

Immune complexes and humoral response to Pseudomonas aeruginosa in cystic fibrosis

1 reference

12 December 2020

In vitro inhibition of lymphocyte proliferation by Pseudomonas aeruginosa phenazine pigments.

1 reference

12 December 2020

Ultrastructure and function of alveolar macrophages from cystic fibrosis patients

1 reference

12 December 2020

Natural history of alpha-1-protease inhibitor deficiency

1 reference

12 December 2020

Antiphagocytic Effect of Slime from a Mucoid Strain of Pseudomonas aeruginosa

1 reference

12 December 2020

Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity

1 reference

12 December 2020

The carbohydrate content of IgG from patients with cystic fibrosis

1 reference

12 December 2020

Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro

1 reference

12 December 2020

Inhibition of human natural killer cell activity by Pseudomonas aeruginosa alkaline protease and elastase

1 reference

12 December 2020

Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung

1 reference

12 December 2020

Selective Modulation of the CD4 Molecular Complex by Pseudomonas aeruginosa Alkaline Protease and Elastase

1 reference

12 December 2020

Inhibitory effect of cystic fibrosis serum on pseudomonas phagocytosis by rabbit and human alveolar macrophages

1 reference

12 December 2020

Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis

1 reference

12 December 2020

Altered antibody isotype in cystic fibrosis: possible role in opsonic deficiency.

1 reference

12 December 2020

Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease

1 reference

12 December 2020

Functional differences between the 40 kDa and 50 to 70 kDa IgG Fc receptors on human neutrophils revealed by elastase treatment and antireceptor antibodies.

1 reference

12 December 2020

Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains

1 reference

12 December 2020

Microbial Elastases. A Comparative Study

1 reference

12 December 2020

Relationship of iron and extracellular virulence factors to Pseudomonas aeruginosa lung infections

1 reference

12 December 2020

Immune complexes and complement abnormalities in patients with cystic fibrosis. Increased mortality associated with circulating immune complexes and decreased function of the alternative complement pathway

1 reference

12 December 2020

Evidence for the presence of components of the alternative (properdin) pathway of complement activation in respiratory secretions

1 reference

12 December 2020

Cleavage of IgG by elastase-like protease (ELP) of human polymorphonuclear leukocytes (PMN): isolation and characterization of Fab and Fc fragments and low-molecular-weight peptides. Stimulation of granulocyte function by ELP-derived Fab and Fc frag

1 reference

12 December 2020

Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis

1 reference

12 December 2020

Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis

1 reference

12 December 2020

Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay

1 reference

12 December 2020

Reticuloendothelial Clearance in Cystic Fibrosis and Other Inflammatory Lung Diseases

1 reference

12 December 2020

Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases

1 reference

12 December 2020

Eicosanoids and lung inflammation

1 reference

12 December 2020

Role of Exotoxin and Protease as Possible Virulence Factors in Experimental Infections with Pseudomonas aeruginosa

1 reference

12 December 2020

Opsonic defect in patients with cystic fibrosis of the pancreas

1 reference

12 December 2020

Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa

1 reference

12 December 2020

Antiphagocytic effect of Pseudomonas aeruginosa exopolysaccharide

1 reference

12 December 2020

Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage

1 reference

12 December 2020

10.1007/978-1-4612-0475-6_8

Identifiers

DOI

0 references

1 reference